1. Home
  2. INTT vs ABOS Comparison

INTT vs ABOS Comparison

Compare INTT & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTT
  • ABOS
  • Stock Information
  • Founded
  • INTT 1981
  • ABOS 1996
  • Country
  • INTT United States
  • ABOS United States
  • Employees
  • INTT N/A
  • ABOS N/A
  • Industry
  • INTT Semiconductors
  • ABOS Biotechnology: Pharmaceutical Preparations
  • Sector
  • INTT Technology
  • ABOS Health Care
  • Exchange
  • INTT Nasdaq
  • ABOS Nasdaq
  • Market Cap
  • INTT 77.3M
  • ABOS 82.4M
  • IPO Year
  • INTT 1997
  • ABOS 2021
  • Fundamental
  • Price
  • INTT $6.85
  • ABOS $1.42
  • Analyst Decision
  • INTT Strong Buy
  • ABOS Strong Buy
  • Analyst Count
  • INTT 2
  • ABOS 3
  • Target Price
  • INTT $12.00
  • ABOS $6.33
  • AVG Volume (30 Days)
  • INTT 28.5K
  • ABOS 314.6K
  • Earning Date
  • INTT 08-06-2025
  • ABOS 08-12-2025
  • Dividend Yield
  • INTT N/A
  • ABOS N/A
  • EPS Growth
  • INTT N/A
  • ABOS N/A
  • EPS
  • INTT N/A
  • ABOS N/A
  • Revenue
  • INTT $121,642,000.00
  • ABOS N/A
  • Revenue This Year
  • INTT N/A
  • ABOS N/A
  • Revenue Next Year
  • INTT $10.07
  • ABOS N/A
  • P/E Ratio
  • INTT N/A
  • ABOS N/A
  • Revenue Growth
  • INTT N/A
  • ABOS N/A
  • 52 Week Low
  • INTT $5.24
  • ABOS $0.86
  • 52 Week High
  • INTT $9.77
  • ABOS $3.36
  • Technical
  • Relative Strength Index (RSI)
  • INTT 43.62
  • ABOS 53.03
  • Support Level
  • INTT $6.98
  • ABOS $1.24
  • Resistance Level
  • INTT $7.40
  • ABOS $1.50
  • Average True Range (ATR)
  • INTT 0.36
  • ABOS 0.11
  • MACD
  • INTT -0.03
  • ABOS -0.01
  • Stochastic Oscillator
  • INTT 5.10
  • ABOS 56.10

About INTT inTest Corporation

inTest Corp is a supplier of test and process solutions for use in manufacturing and testing across a range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. The company manages its business as three operating segments which is also their reporting units that includes Electronic Test, Environmental Technologies and Process Technologies. Electronic Test (which includes semiconductor test equipment, flying probe and in-circuit testers), Environmental Technologies (which includes its thermal test, process and storage products) and Process Technologies (which includes induction heating and video imaging products). The company operates their business and sells its products both domestically and internationally.

About ABOS Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.

Share on Social Networks: